Thank you for your continued patience as we work to return our formula products to the market as soon as possible. We promised to provide you with updates every couple of weeks and wanted to share with you current updates of U.S. metabolic products release.
Please note that timings have shifted on a few of our products; specifically, those products which were originally scheduled to ship in November have now been moved to December and January. This revised schedule is reflected in the table below. All other dates for other products remain the same since our last communication with you.
Meanwhile, Abbott has sufficient supply of all our metabolic products to support urgent patient needs in the United States through the Abbott Metabolic Formulas Urgent Needs Program until newly manufactured metabolic product is released. If you need product urgently, please contact your health care professional.
After product is released, it can take up to four weeks for products to be available through standard channels such as home medical suppliers, distributors, and state programs.
Estimated Release Month for the U.S. | Product |
Currently shipping (September 2022) |
Calcilo®, ProViMin®
|
October 2022 | Pro-Phree®, Ketonex®-1 and 2, Phenex®-1, Similac PM 60/40®, Cyclinex®-1, I-Valex®-1, Glutarex®-1, Propimex®-1 |
December 2022 | Phenex-2 Unflavored and Vanilla, I-Valex-2, Cyclinex-2, Hominex®-2, Propimex-2 |
January 2023 | Hominex-1, Tyrex®-1 and 2, Glutarex-2 |
Full statement here.